NEW YORK, Jan. 4, 2007 (PRIME NEWSWIRE) -- National Stem Cell Holding, Inc. (Pink Sheets:NHGI) announced today the intent to file form 10KSB with the Securities and Exchange Commission at the completion of its audit of FY 2006. After the filing, the company anticipates moving to the OTC Bulletin Board.
Michael Cohen, CEO of National Stem Cell Holding, Inc. stated, "By becoming fully reporting and moving off the Pink Sheets, we hope to further enhance National Stem Cell's ability to support our research goals and infrastructure. This will facilitate our efforts to find therapies for devastating conditions such as diabetes and will also allow us to bring our unique model of free umbilical cord blood banking to a wider demographic. We feel these steps will increase company exposure to the investment community."
National Stem Cell Holding, Inc. is a biotechnology company headquartered in New York City dedicated to the advancement of regenerative medicine. Through its sponsored research agreement with the Johns Hopkins University School of Medicine's Institute for Cell Engineering, National Stem Cell is focused on the development of potential stem cell therapies for the treatment of diabetes and cardiac injury. The company is developing a genetically diverse umbilical cord blood bank to meet the growing need for transplant grade umbilical cord blood stem cells. National Stem Cell Holding, Inc. is the parent company of National Stem Cell, Inc., incorporated in 2005, which operates the Sperm Bank of New York as a wholly owned subsidiary. For more information, please visit www.nationalstemcell.com.
Forward Looking Statements
As provided by the "Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995," National Stem Cell Holding, Inc. cautions readers that this Press Release includes certain information which constitutes forward-looking statements. Such forward-looking statements address the company's intentions, hopes, expectations, strategies, and financial or business outlook for the future. The statements are based on management's current beliefs and expectations and thus, apply only as of the date of this Press Release. There are a number of risks and uncertainties that could cause actual results or events to differ materially from management's current beliefs and expectations. Risk factors include but are not limited to National Stem Cell Holding, Inc.'s ability to successfully complete its 2006 financial audit, as well as general economic, competitive, governmental and technological factors. National Stem Cell Holding, Inc. does not undertake any obligation or responsibility to update forward-looking statements.